Introduction

Hip fractures represent a significant public health concern, often leading to disability, reduced quality of life, and increased mortality, particularly in the elderly population. As the global population ages, the incidence of hip fractures is expected to rise dramatically. By 2025, the worldwide number of hip fractures is projected to reach 2.6 million, increasing further to 6.25 million by 2050 (1–3).

Trochanteric fractures involve the proximal femur, specifically the region between the femoral neck and the shaft. Subtrochanteric fractures, characterized by a fracture line extending up to 5 cm distal to the lesser trochanter, are often included in this definition. Various classification systems exist for trochanteric fractures, typically based on the location of the fracture line and the degree of displacement, which impacts external reduction techniques (4–7). Two widely recognized classifications are the Evans classification, later modified by Jensen and Michaelsen, and the AO/OTA Classification. The Evans classification categorizes fractures based on stability, ranging from non-displaced two-fragment fractures (Type I) to more complex comminuted fractures involving medial and posterolateral displacement. The AO/OTA Classification, developed by the AO Foundation and adopted by the Orthopaedic Trauma Association, further aids in the classification of these injuries. (8–13).

Trochanteric fractures are frequently addressed surgically, with sliding hip screws (SHS) and intramedullary nails (IMN) being the two most widely used fixation techniques (14). Although many studies report no significant differences in outcomes between these methods, this may be attributed to including all types of trochanteric fractures in the analysis. Recent research tends to focus on stable and unstable fracture categories without detailed consideration of the specific AO/OTA subtypes (31A1, 31A2, 31A3), which could make findings more clinically relevant (15–17). Current guidelines, such as the Dutch Guideline, recommend extramedullary fixation for AO 31-A1 and 31-A2 fractures due to their superior cost-effectiveness, mainly driven by lower implant costs. Nonetheless, extramedullary and intramedullary fixation is acceptable for 31-A2 fractures, with no definitive evidence supporting one method over the other. Earlier studies, particularly those evaluating first-generation cephalomedullary nails, raised concerns about higher failure and reoperation rates with intramedullary devices. Despite this, the use of IMN has increased significantly in recent years, accounting for up to 90% of procedures in the US, as recent data indicates better outcomes. However, this growing preference may also be influenced by factors other than purely clinical outcomes, leaving the best treatment approach a subject of ongoing debate (18,19,19–23).

The objective of this study was to evaluate the intraoperative and postoperative differences between intramedullary nailing and dynamic hip screw fixation in patients with trochanteric fractures compare between the results of the most recent evidence and the previous published meta-analysis.

Methods

2.1 Data Sources and Search Strategy

This study adhered to the recommendations set forth by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) Statement and the Cochrane Handbook for Systematic Reviews of Interventions. A comprehensive literature search was performed across PubMed, Scopus, Web of Science, and the Cochrane Library databases, covering publications up to September 2024. The specific search strategies employed for each database can be found in Supplementary File 1. The study protocol was registered in the international prospective register of systematic reviews, PROSPERO (CRD42024583373)

2.2 Eligibility Criteria and Selection Process

We included the clinical trials and observational comparative studies published in English till September 2024 and have an accessible full text focusing on the patients with trochanteric fractures who underwent IMN Vs. DHS. However, we excluded studies that were animal-based, laboratory-based, basic science, cadaveric, editorial, or published in languages other than English.

Based on the previous specific criteria, two authors independently reviewed each study’s title and abstract in the prescreening process and the full text in the whole text screening process to ensure that all included studies met the inclusion criteria.

2.3 Data extraction tool and items

Another four authors were responsible for data extraction using an Excel spreadsheet. Two authors extracted a summary of the included studies, including the following items: title, study design, site, population, intervention, comparator, follow-up duration (in weeks) and sample size. The other two authors extracted baseline demographics and outcomes reported in the included studies, which included age, BMI, sex, fracture classification, American Society of Anesthesiologists (ASA) score, and side of fracture.

2.4 Outcomes measurement

Primary outcomes: open reduction of fracture, blood loose (ml), time to healing (days) and femoral neck shortening (mm)

Secondary outcomes: required blood transfusion (UNITS), Patients need Blood transfusion, screening time (min), mean surgical time (min), hospital stay (days), mean Harris hip score and mobility score and Parker Mobility Score

2.5 Quality assessment

The quality of the randomized control trials (RCTs) was assessed independently by two authors using The Cochrane Collaboration’s tool for assessing the risk of bias (ROB-1) (24) and the cohort studies included were evaluated by another two authors using the Newcastle-Ottawa Scale (NOS) (25).

2.6 Statistical analysis

The meta-analysis was conducted using Stata 17, employing mean difference (MD) or standardized mean difference (SMD) effect sizes for continuous outcomes and log odds-ratio effect size for binary outcomes. A random-effects model was utilized to account for study heterogeneity. Statistical significance was determined with a p-value of less than 0.05 and a 95% confidence interval (95% CI). Heterogeneity was considered significant if I² was greater than 50% and the p-value was below 0.1. Subgroup analyses were performed based on study design, and meta-regression was used to assess covariates' impact, such as age and gender. Additionally, trial sequential analysis (TSA) (26) and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) (27) were employed to evaluate the robustness and overall quality of the evidence for the primary outcomes.

2.7 Publication bias

Publication bias across all outcomes was evaluated using funnel plot visualization and egger test (28).

Results

3.1 Study Selection and Data Extraction

The initial search retrieved 3,740 research papers. After removing 540 duplicates, 3,200 papers remained for title and abstract screening. After excluding 3,061 studies, 139 papers entered the full-text screening process. Based on the prespecified inclusion and exclusion criteria, we included 60 studies in the final analysis, which comprised 31 randomized controlled trials (RCTs) and 29 cohort studies. The total number of participants is 88256 patients, ranging from 39 in the most minor cohort study to 34759 in the largest cohort studies, with follow-up periods varying from 1 to 212 weeks. This process is presented in Supplementary file 1. The summary of the studies included is presented in Table 1 and the baseline characteristics is presented in Supplementary file 1.

Table 1. Summary of the included studies
study IDtitledesignsitepopulationInterventioncomparatorfollow up (weeks)sample size
Adams 2001Prospective randomized controlled trial of an intramedullary nail versus dynamic screw and plate for intertrochanteric fractures of the femurRCTUKpatients admitted from the local population with intertrochanteric fractured femursGNDHS48400
Adeel 2020Comparison of proximal femoral nail (PFN) and dynamic hip screw (DHS) for the treatment of AO type A2 and A3 pertrochanteric fractures of femurRCTPakistanpatients aged 40-75 years with Arbeitsgemeinschaft für Osteosynthesefragen type A2 and A3 per trochanteric fracturesPFNDHS4868
Ahmad 2019Injury specific trauma registry: Outcomes of a prospective cohort with proximal femur fracturesProspective CohortPakistanPatients with isolated neck of femur or intertrochanteric fractures between 2015 and 2018 at Aga Khan UniversityIMNDHS52138
Ahrengart 2002A randomized study of the compression hip screw and Gamma nail in 426 fracturesRCTSweden, FinlandFour hundred twenty-six patients with intertrochanteric fracturesGNDHS24426
Aktselis 2014Prospective randomised controlled trial of an intramedullary nail versus a sliding hip screw for intertrochanteric fractures of the femurRCTGreecepatients with a 31-A2.2 or A2.3 Arbeitsgemeinschaft für Osteosynthesefragen/Orthopaedic Trauma Association (AO/OTA) intertrochanteric fractureGNDHS4871
Arshad 2021Dynamic hip screw fxation of subtrochanteric femoral fracturesRetrospective cohortUK86 patients presented with a subtrochanteric fracture of the femurIMNDHS-86
Avakian 2011Dynamic hip screws versus proximal femoral nails for intertrochanteric fracturesRetrospective cohortAustralia144 patients with intertrochanteric fracturesPFNDHS-144
Barton 2010A comparison of the long gamma nail with the sliding hip screw for the treatment of AO/OTA 31-A2 fractures of the proximal part of the femur: a prospective randomized trialRCTUKTwo hundred and ten patients presenting with an AO/OTA 31-A2 fracture of the proximal part of the femurGNDHS48210
Berney 2024Is the increased use of intramedullary nailing over DHS for intertrochanteric hip fractures justified? – A review of the Irish hip fracture database 2016 –2020Retrospective cohortIrelandPatients with intertrochanteric fractures older than 60 yearsDHSIMN-5668
Butt 1995Comparison of dynamic hip screw and gamma nail: a prospective, randomized, controlled trialRCTUK 95 consecutive pafients with peri-trochnteric fractures of the femur.GNDHS-95
Carruli 2017A comparison of two fixation methods for femoral trochanteric fractures: a new generation intramedullary system vssliding hip screwRCTSwitzerlandpatients affected by a trochanteric fracture, treated between January 2007 to December 2009PFNADHS12128
Chau 2013Cephalomedullary nail versus sliding hip screw for unstable intertrochanteric fractures in elderly patientscohortSingapore63 elderly patients aged ≥60 years with unstable intertrochanteric fractures (AO types A2 and A3)PFNADHS4863
Chen 2013Convergence of Outcomes for Hip Fracture Fixation by Nails and PlatesRetrospective cohortUSApatients who sustained a hip fracture by the International Classification of DiseasesIMNDHS488924
Das 2020Osteosynthesis of intertrochanteric fracturesby PFN and DHS – A prospective randomized comparative studyRCTIndia150 patients of unstable ITF (AO type 31-A2, 31-A3) in elderly (with age more than 50 years)PFNDHS48150
Duan 2017Comparison of the curative effects of PFNA and DHS fixation in treating intertrochanteric fractures in elderly patientsRetrospective cohortChinaPatients aged between 60-92 years old admitted with intertrochanteric fracturesPFNADHS78108
Dunne 2021Comparison of outcomes after different methods of fixation for extracapsular hip fractures: An observational studyRetrospective cohortEnglandPatients with stable and unstable hip fracturesPFNADHS521335
Gawronska 2022 (Aug)Holistic Symmetry Assessment Using Pedobarography after Treatment of Pertrochanteric Fractures in Elderly PatientsProspective cohortPolandElderly patients aged 65+ with pertrochanteric fracturesIMNDHS3660
Gawronska 2022 (Feb)Functional Symmetry after Surgical Treatment of Pertrochanteric Fractures in the ElderlyProspective cohortPolandAdults with pertrochanteric femoral fractures.IMNDHS2478
Grezda 2021Comparison of systemic inflammatory responses of proximal femoral nail versus dynamic hip screw after treatment of patients with pertrochanteric fractures: A prospective comparative studyProspective cohortKosovopatients older than 60 with trochanteric region fractures AO/OTA 31.A1–31.A2DHSPFN140
Hardy 1998Use of an intramedullary hip-screw compared with a compression hip-screw with a plate for intertrochanteric femoral fractures. A prospective, randomized study of one hundred patientsRCTBelgiumelderly patients who had an intertrochanteric femoral fractureGNDHS48100
Harrington 2002Intramedullary hip screw versus sliding hip screw for unstable intertrochanteric femoral fractures in the elderlyRCTUKpatients with unstable trochanteric fractures above 65 years of age, without a previous proximal femoral fractureIMNDHS48102
Hoffman 1996Intertrochanteric fractures of the femur: a randomized prospective comparison of the Gamma nail and the Ambi hip screwRCTNew Zealandpatients over the age of 50 years with intertrochanteric femoral fracturesGNDHS9667
Huang 2017Comparison of the Clinical Effectiveness of PFNA, PFLCP, and DHS in Treatment of Unstable Intertrochanteric Femoral FractureRCTChinapatients with unstable intertrochanteric femoral fracture were extracted from the archived records at the department of orthopedics of Linyi Second People’s HospitalPFNADHS9660
Kassem 2022Functional and radiological outcomes of dynamic hip screw with trochanteric stabilizing plate versus short proximal femoral nail in management of unstable trochanteric fractures: A randomized-controlled trialRCTEgyptpatients above the age of 60 years with isolated unstable trochanteric fractures (AO/OTA 31-A2).PFNDHS+TSP5268
Kim 2020Single screw type of lag screw results higher reoperation rate in the osteosynthesis of basicervical hip fractureRetrospective cohortSouth KoreaPatients with basicervical hip fracture of the proximal part of the femurCMNDHS104106
Kim 2022What Is the Best Treatment Choice for Concomitant Ipsilateral Femoral Neck and Intertrochanteric Fracture? A Retrospective Comparative Analysis of 115 Consecutive PatientsRetrospective cohortRepublic of KoreaPatients diagnosed with concomitant ipsilateral femoral neck and intertrochanteric fractures (CIFNITF) who underwent surgical treatment.PFN-ADHS4884
Kleftouris 2023Endovis Nail versus Dynamic Hip Screw for Unstable Pertrochanteric Fractures: A Feasibility Randomised Control Trial including Patients with Cognitive ImpairmentRCTHelsinki60 consecutive patients with an unstable pertrochanteric (OTA/AO 31-A2) fractureIMNDHS1260
Konda 2021Risk Stratification of Operatively Treated Intertrochanteric Hip Fractures Reveals Differences in Short-Term Outcomes and Procedure Costs Between Sliding Hip Screw Versus Short Cephalomedullary NailRetrospective cohortUSAGeriatric patients (aged 55 years and older) with intertrochanteric hip fracturesshort CMNSHS48458
Kumar 2011Comparative prospective study of proximal femoral nail and dynamic hip screw in treatment of intertrochanteric fracture femurProspective cohortIndiacases of intertrochanteric fractures of the femur, involving patients more than 50 years oldPFNDHS4850
Little 2008A prospective trial comparing the Holland nail with the dynamic hip screw in the treatment of intertrochanteric fractures of the hipRCTUKpatients who presented with an extra-capsular intertrochanteric hip fractureHolland NailDHS48190
Marks 2021Quality of life, walking ability and change of living situation after trochanteric femur fracture in geriatric patients-Comparison between sliding hip screw and cephalomedullary nails from the registry for geriatric traumaRetrospective cohortGermanypatients treated hip fractures between 2016 and 2019CMNSHS1710995
Mazzola 2022Dynamic hip screw versus intramedullary nailing for the treatment of A1 intertrochanteric fractures: A retrospective, comparative study and cost analysisRetrospective CohortItalypatients experiencing emergency department diagnosis of proximal femoral fracture in January 1st, 2015 and December 31st, 2019.IMNDHS20185
Pajarinen 2004Femoral shaft medialisation and neck-shaft angle in unstable pertrochanteric femoral fracturesRCTSwitzerlandpatients with an unstable, low-energy, extracapsular, pertrochanteric femoral fracture (AO category 31-A, class A2)PFNDHS1648
Pajarinen 2005Pertrochanteric femoral fractures treated with a dynamic hip screw or a proximal femoral nail. A randomised study comparing post-operative rehabilitationRCTFinland patients with a pertrochanteric femoral fracturePFNDHS16108
Parker 2012Sliding hip screw versus the Targon PF nail in the treatment of trochanteric fractures of the hip: a randomised trial of 600 fracturesRCTUK598 patients with 600 trochanteric fractures of the hipTargon PFDHS48600
Parker 2017Sliding hip screw versus intramedullary nail for trochanteric hip fractures; a randomised trial of 1000 patients with presentation of results related to fracture stabilityRCTUKpatients with stable (A1), unstable (A2), and transtrochanteric (A3) fractures, excluding pathological and subtrochanteric fractures.IMNSHS-1000
Parker-Cawley 2017Sliding hip screw versus the Targon PFT nail for trochanteric hip fractures: a randomised trial of 400 patientsRCTUKpatients with trochanteric hip fracturesTargon PFDHS48400
Pehli̇Vanoğlu 2021Proximal femoral nailing versus dynamic hip screw in management of stable intertrochanteric femur fractures: a comparison of clinical and radiological outcomesRetrospective CohortturkeyPatients who underwent surgical treatment for a SIFF in the departmentPFNADHS24122
Reindl 2015Intramedullary Versus Extramedullary Fixation for Unstable Intertrochanteric Fractures: A Prospective Randomized Controlled TrialRCTCanadapatients aged 55 and older with Type-A2 intertrochanteric fracturesIMNDHS48194
Saarenpää 2006Treatment of subtrochanteric fractures. A comparison of the Gamma nail and the dynamic hip screw: short-term outcome in 58 patientsCohortFinland1,511 patients with 1,624 femoral hip fractures, aged over 49 years, treated between 1991 and 1999.GNDHS5258
Sadowski 2002Treatment of Reverse Oblique and Transverse Intertrochanteric Fractures with Use of an Intramedullary Nail or a 95° Screw-PlateRCTSwitzerlandelderly patients with AO/OTA 31-A3 intertrochanteric femur fracturesPFNDCH4839
Sahin 2012Dynamic hip screw versus proximal femoral nail for treatment of trochanteric hip fractures: an outcome analyses with a minimum 2 years of follow-upRetrospective CohortTurkeypatients who underwent surgery for extracapsular pertrochanteric hip fractures between 2005 and 2010PFNADHS96181
Saleem 2020Comparison of unstable inter-trochanteric femur fracture treated with Dynamic Hip Screw and Proximal Femur NailRCTPakistanPatients aged 40-80 years with radiological evidence of unstable inter-trochanteric fracture not more than three weeks old and willing to provide informed consentPFNDHS24108
Sanders 2017A Multicenter Randomized Control Trial Comparing a Novel Intramedullary Device (InterTAN) Versus Conventional Treatment (Sliding Hip Screw) of Geriatric Hip FracturesRCTCanadaTwo hundred forty-nine patients 55 years of age or older with AO/OTA 31A1 (43) and OA/OTA 31A2 (206) fractures were prospectively enrolled and followed for 12 months.InterTANDHS48249
Saudan 2002Pertrochanteric fractures: is there an advantage to an intramedullary nail?: a randomized, prospective study of 206 patients comparing the dynamic hip screw and proximal femoral nailRCTSwitzerlandAll patients over the age of fifty-five years presenting with fractures of the trochanteric region caused by a lowenergy injury, classified as AO/OTA Type 31-A1 and A2PFNDHS48206
Schemitsch 2023Intramedullary Nailing vs Sliding Hip Screw in Trochanteric Fracture Management: The INSITE Randomized Clinical TrialRCTINSITE Investigatorspatients aged 18 years and older with low-energy trochanteric fractures (AO/OTA type 31-A1 or 31-A2)IMNDHS52833
Singh 2019Is PFNA-II a better implant for stable intertrochanteric fractures in elderly population ? A prospective randomized studyRCTIndiaelderly patients with stable intertrochanteric fractures treated with DHS and PFNA-II between August 2014 to Dec 2016PFNADHS4860
Talmac 2019Examining implant superiority in the treatment of simple pertrochanteric fractures of the proximal femur in elderly patientsRetrospective Cohortturkeyelderly patients diagnosed with simple pertrochanteric fractures (AO/OTA 31A1)PFNADHS52141
tarantino 2005A comparative prospective study of dynamic variable angle hip screw and Gamma nail in intertrochanteric hip fracturesProspective cohortItalypatients with AO/OTA Type 31-A1; A2; A3 and B2 intertrochanteric hip fracturesGNDMS52142
Tian 2022A Retrospective Study of 98 Elderly Patients with High-Risk Lateral Femoral Wall Intertrochanteric Hip Fractures to Compare Outcomes Following Surgery with Proximal Femoral Nail Antirotation (PFNA) Versus Dynamic Hip Screw (DHS)Retrospective CohortChinapatients with high-risk intertrochanteric fractures of the lateral wall who underwent surgery from January 2019 to December 2020PFNADHS2698
Utrilla 2005Trochanteric gamma nail and compression hip screw for trochanteric fractures: a randomized, prospective, comparative study in 210 elderly patients with a new design of the gamma nailRCTSpainpatients older than 65 years with trochanteric femoral fracturesGNDHS48210
Warren 2019Cephalomedullary nailing versus sliding hip screws for Intertrochanteric and basicervical hip fractures: a propensity-matched study of short-term outcomes in over 17,000 patientsRetrospective CohortUSpatients with a BC femoral neck fracture or a peritrochanteric hip fractureCMNSHS417000
Werner 2015Trends in the management of intertrochanteric femur fractures in the United States 2005-2011Retrospective cohortNationwide database of Medicare patientsPatients with proximal femur fractures from 2005 to 2011IMNSHS-34759
Xu 2010A comparison of the proximal femoral nail antirotation device and dynamic hip screw in the treatment of unstable pertrochanteric fractureRCTChinapatients with unstable proximal femoral fractures (AO category 31-A2) admitted to a hospital between August 2006 and June 2008.PFNADHS48106
Yeganeh 2016Comparing the Intramedullary Nailing Method Versus Dynamic Hip Screw in Treatment of Unstable Intertrochanteric FracturesRetrospective cohortIranpatients with unstable Intertrochanteric fracturePFNDHS24114
Yu 2016Proximal femoral nails anti-rotation versusdynamic hip screws for treatment of stable intertrochanteric femur fractures: an outcome analyses with a minimum 4 yearsof follow-upRetrospective cohortChinapatients age of 60–92 years, good cognitive function, a stable IFF(type AO/ OTA 31.A1.1, 1.2, 1.3)PFNADHS212222
Zang 2018A comparative study of proximal femoral locking compress plate, proximal femoral nail antirotation and dynamic hip screw in intertrochanteric fracturesRetrospective cohortchinapatients with intertrochanteric femur fractures admitted between January 2015 and December 2016PFNADHS26100
Zehir 2015Proximal femoral nail antirotation against dynamic hip screw for unstable trochanteric fractures; a prospective randomized comparisonRCTTurkeyPatients with AO type 31.A2 fracture on plain radiographs and aged above 65 yearsPFNADHS24198
zeng 2017Proximal femoral nail antirotation versus dynamic hip screw fixation for treatment of osteoporotic type 31-A1 intertrochanteric femoral fractures in elderly patientsRetrospective cohortChinaPatients aged 60–92 years with osteoporotic 31-A1 intertrochanteric femoral fracturesPFNADHS48222
Zou 2009A comparison of proximal femoral nail antirotation and dynamic hip screw devices in trochanteric fracturesRCTChinapatients with low-energy trochanteric femoral fracturesPFNADHS48121

3.2 Quality assessment

The quality assessment of the included RCTs indicates a generally high methodological rigor. Specifically, 24 of 31 RCTs received a "high quality" rating (29–52). Six studies were rated "moderate quality" (53–58), indicating some potential limitations in methodology. Only one study was rated "low" (59) suggesting more significant methodological concerns that could affect the study's reliability. Supplementary file 1.

The quality assessment of the included cohort studies reveals a strong overall standard. Out of the 29 studies evaluated, 26 received a "Good" rating (60–85), while three studies were rated as "Fair" (86–88). The "Fair" rating indicates the presence of some methodological limitations that may affect the reliability or generalizability of the findings. Supplementary file 1.

3.3 Intraoperative differences

The meta-analysis revealed the following results: For open reduction of fracture, the log odds ratio was -1.52 (95% CI [-3.31; 0.28], I² = 86.07%, p-value = 0.10), indicating no statistically significant difference Figure 1A. Regarding the need for blood transfusions, the log odds ratio was -0.65 (95% CI [-1.40; 0.09], I² = 95.85%, p-value = 0.09), suggesting a trend favoring IMN, though not statistically significant Figure 1B. The analysis also revealed a mean difference of -0.06 units (95% CI [-0.14; 0.03], I² = 21.05%, p-value = 0.18) for required blood transfusions, indicating minimal clinical relevance Figure 1C. Screening time was slightly longer for IMN, with a mean difference of 0.52 minutes (95% CI [0.03; 1.02], I² = 99.75%, p-value < 0.05) Figure 1D. In terms of blood loss, IMN showed a significant reduction with a mean difference of -98.80 ml (95% CI [-127.96; -69.64], I² = 99.51%, p-value < 0.01), demonstrating a clear advantage for this technique in minimizing intraoperative hemorrhage Figure 2. Finally, the mean surgical time favored IMN with a significant reduction of -9.47 minutes (95% CI [-14.15; -4.80], I² = 98.79%, p-value < 0.01) Figure 3.

Forest plots of intraoperative outcomes, intramedullary nailing versus dynamic hip screw
Figure 1 Forest plots of intraoperative outcomes, intramedullary nailing versus dynamic hip screw (A) Open reduction of the fracture: log odds ratio −1.52 (95% CI −3.31 to 0.28), I² = 86.07%, p = 0.10. (B) Patients needing blood transfusion: log odds ratio −0.65 (95% CI −1.40 to 0.09), I² = 95.85%, p = 0.09. (C) Required blood transfusion (units): mean difference −0.06 units (95% CI −0.14 to 0.03), I² = 21.05%, p = 0.18. (D) Screening time (min): mean difference 0.52 min (95% CI 0.03 to 1.02), I² = 99.75%, p < 0.05. Random-effects meta-analysis. IMN, intramedullary nailing; DHS, dynamic hip screw; CI, confidence interval.
Download
Forest plot of intraoperative blood loss (ml), intramedullary nailing versus dynamic hip screw
Figure 2 Forest plot of intraoperative blood loss (ml), intramedullary nailing versus dynamic hip screw Mean difference −98.80 ml (95% CI −127.96 to −69.64), I² = 99.51%, p < 0.01, favouring intramedullary nailing. Random-effects meta-analysis. IMN, intramedullary nailing; DHS, dynamic hip screw; CI, confidence interval.
Download
Forest plot of mean surgical time (min), intramedullary nailing versus dynamic hip screw
Figure 3 Forest plot of mean surgical time (min), intramedullary nailing versus dynamic hip screw Mean difference −9.47 min (95% CI −14.15 to −4.80), I² = 98.79%, p < 0.01, favouring intramedullary nailing. Random-effects meta-analysis. IMN, intramedullary nailing; DHS, dynamic hip screw; CI, confidence interval.
Download

3.4 Postoperative differences

In terms of hospital stay, IMN demonstrated a slight advantage over DHS fixation, with a significant standardized mean difference of -0.22 (95% CI [-0.33; -0.10], I² = 90.71%, p < 0.01), indicating a modest reduction in hospital days for IMN patients Figure 4. For time to healing, IMN showed a statistically significant improvement with a mean difference of -6.92 days (95% CI [-12.55; -1.29], I² = 95.04%, p = 0.02), suggesting a quicker recovery period compared to DHS Figure 5A. However, no significant difference was observed in femoral neck shortening, with a mean difference of -1.19 mm (95% CI [-4.21; 1.83], I² = 99.76%, p = 0.44) Figure 5B. Mean PMS did not differ significantly between IMN and DHS, with a standardized mean difference of 0.18 (95% CI [-0.17; 0.53], I² = 85.30%, p = 0.31), indicating comparable functional outcomes for both techniques Figure 5C. Similarly, mean HHS did not differ significantly, with a standardized mean difference of 0.01 (95% CI [-0.70; 0.72], I² = 97.41%, p = 0.97) Figure 6.

Forest plot of hospital stay (days), intramedullary nailing versus dynamic hip screw
Figure 4 Forest plot of hospital stay (days), intramedullary nailing versus dynamic hip screw Standardised mean difference −0.22 (95% CI −0.33 to −0.10), I² = 90.71%, p < 0.01, favouring intramedullary nailing. Random-effects meta-analysis. IMN, intramedullary nailing; DHS, dynamic hip screw; CI, confidence interval.
Download
Forest plots of postoperative outcomes, intramedullary nailing versus dynamic hip screw
Figure 5 Forest plots of postoperative outcomes, intramedullary nailing versus dynamic hip screw (A) Time to healing (days): mean difference −6.92 days (95% CI −12.55 to −1.29), I² = 95.04%, p = 0.02. (B) Femoral neck shortening (mm): mean difference −1.19 mm (95% CI −4.21 to 1.83), I² = 99.76%, p = 0.44. (C) Parker Mobility Score: standardised mean difference 0.18 (95% CI −0.17 to 0.53), I² = 85.30%, p = 0.31. Random-effects meta-analysis. IMN, intramedullary nailing; DHS, dynamic hip screw; CI, confidence interval.
Download
Forest plot of mean Harris Hip Score, intramedullary nailing versus dynamic hip screw
Figure 6 Forest plot of mean Harris Hip Score, intramedullary nailing versus dynamic hip screw Standardised mean difference 0.01 (95% CI −0.70 to 0.72), I² = 97.41%, p = 0.97; no significant difference. Random-effects meta-analysis. IMN, intramedullary nailing; DHS, dynamic hip screw; CI, confidence interval.
Download

3.5 Subgroup analysis

In the subgroup analysis by study design (RCTs vs. NRCTs), no statistically significant differences were observed between RCTs and NRCTs across most outcomes. Specifically, tests of subgroup differences outcomes such as open reduction of fracture (p = 0.11) Supplementary File 1, blood loss (p = 0.74) Supplementary File 1, patients needing blood transfusion (p = 0.58) Supplementary File 1, mean surgical time (p = 0.24) Supplementary File 1, hospital stay (p = 0.89) Supplementary File 1, mean HHS (p = 0.36) Supplementary File 1, and healing time (p = 0.89) showed similar results between RCTs and NRCTs, with p-values consistently above the 0.05 threshold, indicating non-significance Supplementary File 1. An exception was noted in screening time, where results reached statistical significance for RCTs (p = 0.0) but remained non-significant for NRCTs (p = 0.5) Supplementary File 1. This suggests that study design may influence specific outcomes, such as screening time, but overall, the effect of IMN versus DHS did not substantially differ based on the study design.

3.6 Sensitivity analysis

The sensitivity analysis, conducted using a leave-one-out test, provided valuable insights into the robustness of the meta-analysis. In most cases, removing individual studies did not significantly change the overall results, indicating stability in the findings. However, certain studies did have an impact on specific outcomes. For open reduction of the fracture, statistical significance favoring IMN over DHS (p = 0.029) was observed only after excluding the study by Kassem et al. (2022) Supplementary File 1. Blood loss (ml) demonstrated consistent nonsignificant results across all iterations, with no single study exclusion altering the overall findings Supplementary File 1. Patients requiring blood transfusion showed a statistically significant advantage for IMN (p = 0.01) exclusively after omitting Werner et al. (2015) Supplementary File 1. Conversely, required blood transfusion units remained unaffected by any study exclusion Supplementary File 1. Screening time (min) exhibited heterogeneity; removing specific studies (Utrilla, 2005; Saudan, 2002; Parker, 2012; Singh, 2019; Tarantino, 2005; Talmac, 2019) individually yielded p-values < 0.05, indicating these trials collectively influenced the pooled effect's significance Supplementary File 1. Mean surgical time (min) and hospital stay (days) maintained nonsignificant results regardless of excluded studies Supplementary File 1. Time to healing (days) was only not statistically significant AFTER excluding Huang 2017 (p= 0.051) Supplementary File 1. Femoral neck shortening (mm) achieved statistical significance (p = 0.026) solely after excluding Harrington et al. (2002) Supplementary File 1. Notably, HHS and PMS remained stable, with no single-study exclusion impacting their overall results Supplementary File 1.

3.7 Cumulative analysis

The cumulative analysis revealed several important trends. Initially, while IMN demonstrated significant benefits over DHS for specific outcomes, such as open reduction of fractures, the significance and magnitude of these effects tended to diminish as more studies, particularly Kassem 2022, were included Supplementary File 2. Regarding blood loss, the evidence favoring IMN became statistically significant after incorporating Little 2008 (p = 0.011), with subsequent studies further reinforcing this trend Supplementary File 2. For patients needing blood transfusions, earlier studies supported IMN significantly; however, the addition of more recent studies diluted this significance Supplementary File 2. The analysis also showed that the statistical significance for required blood transfusion units emerged after including Pajarinen 2005 (p = 0.006), but again, it was lost with the addition of newer studies Supplementary File 2. Notably, statistically significant results for screening time increased with the addition of more studies Supplementary File 2. For a mean surgical time, the first statistically significant result appeared when Duan 2017 was added (p = 0.043) Supplementary File 2, while for a hospital stay, the first significant result was observed after including Zang 2018 (p = 0.024) Supplementary File 2. The time to healing showed a similar trend, with the first significant result appearing after adding Tian 2022 (p = 0.039) Supplementary File 2. In contrast, the results for femoral neck shortening, mean HHS, and PMS remained robust and unchanged across the cumulative evidence, suggesting consistency in these findings despite including new data Supplementary File 2.

3.8 Meta regression

In the meta-regression analysis examining the influence of mean age and sex (male), most outcomes showed no statistically significant associations with these variables. For age, a significant coefficient was observed only for mean surgical time (coefficient = 0.969, p = 0.001), suggesting that age may influence surgical duration, potentially extending it. Hospital stay also demonstrated significance with age (coefficient = 0.069, p = 0.000), indicating longer hospital stays with increasing age in this treatment context. For sex (male), a borderline significance was noted for patients needing blood transfusions (coefficient = 0.000175, p = 0.050), suggesting that the male sex might slightly impact transfusion requirements. However, all other associations between age or sex and the various outcomes were non-significant, indicating a limited influence of these demographic factors on the overall effect of IMN versus DHS across most outcomes. Supplementary File 2.

3.9 Trial Sequential Analysis (TSA)

The Trial Sequential Analysis (TSA) results provided critical insights into the robustness of the findings from the meta-analysis. For the outcome of open reduction of fractures, the analysis revealed a sample size of 1313 with a required information size (RIS) of 6977, indicating that the current evidence is insufficient to draw definitive conclusions, as the Z-curve did not reach the upper significance boundary or the futility boundary Supplementary File 2. Regarding blood loss, the TSA reached an RIS of 449, confirming that the accumulated sample size is adequate for evaluating the effectiveness of IMN compared to DHS in this outcome Supplementary File 2. However, for the time to healing, despite a sample size of 1325, the current cumulative sample is below the RIS of 2791, indicating a need for further research to strengthen the conclusions regarding the healing duration associated with each surgical method Supplementary File 2. Lastly, the analysis for femoral neck shortening presented a sample size of 1577 with a high RIS of 29494, suggesting that the evidence remains inconclusive, as the cumulative Z-score has not crossed any efficacy or futility boundary Supplementary File 2.

3.10 GRADE approach

The GRADE approach identified varying levels of evidence quality Table 2. All outcomes exhibited high heterogeneity (I² > 80%). For the outcome of open reduction of the fracture, evidence was rated as very low due to the inclusion of studies using diverse techniques of IMN. In contrast, the blood loss (ml) outcome received a high rating, indicating robust evidence; however, significant heterogeneity in effect estimates was noted. Additionally, there was evidence of publication bias, supported by a significant Egger test p-value of 0.0001. Conversely, time to healing and femoral neck shortening were rated as low, primarily due to high heterogeneity and small sample sizes relative to the required information size.

Table 2. GRADE evidence profile
Certainty assessment№ of patientsEffectCertaintyImportance
№ of studiesStudy designRisk of biasInconsistencyIndirectnessImprecisionOther considerationsIMNDHSRelative
(95% CI)
Absolute
(95% CI)
Open reduction of fracture
8RCTs = 6NRCTs = 2not seriousvery seriousanot seriousbvery seriousc,dnone86/697 (12.3%)115/616 (18.7%)Log odds-ratio -1.52
(-3.31 to 0.28)
-- per 1,000
(from -- to --)
⨁◯◯◯
Very lowa,b,c,d
IMPORTANT
Blood loose (ml)
29RCTs = 19NRCTs = 10not seriousnot seriousenot seriousbnot seriouspublication bias strongly suspected
very strong associationf
21212004-MD 98.8 ml lower
(127.96 lower to 69.64 lower)
⨁⨁⨁⨁
Highb,e,f
CRITICAL
Time to healing (days)
11RCTs = 5NRCTs = 6not seriousseriousanot seriousbseriousdnone659666-MD 6.92 days lower
(12.55 lower to 1.29 lower)
⨁⨁◯◯
Lowa,b,d
IMPORTANT
Femoral neck shortening (mm)
8RCTsnot seriousseriousanot seriousseriousdnone759782-MD 1.19 mm lower
(4.21 lower to 1.83 higher)
⨁⨁◯◯
Lowa,d
IMPORTANT
CI: confidence interval; MD: mean difference. Explanations a. I^2 > 80% b. studies with varied techniques of IMN favored IMN over DHS c. Wide 95% CI d. Small sample size comparing to the RIS e. Most studies favoured IMN but the observed heterogeneity is in the effect estimate f. egger test p value = 0.0001

3.11 Publication bias

The results from the publication bias assessment, evaluated using Egger's test, indicate a significant publication bias for blood loss, with a p-value of 0.0001. This suggests that smaller studies with positive results are more likely to be published, which may skew the findings Supplementary File 2. In contrast, the mean surgical time also showed considerable evidence of bias, with a p-value of 0 Supplementary File 2. Other outcomes, including screening time, hospital stay, Time to Healing (in days) and Mean HHS yielded p-values of 0.2075, 0.1805, 0.1376, and 0.1467, respectively. These results suggest no significant evidence of publication bias for these outcomes Supplementary File 2.

Discussion

The results of this meta-analysis highlight several key findings regarding the comparative effectiveness of IMN versus DHS fixation in the management of trochanteric fractures. Notably, while there was no statistically significant difference in the open reduction of fractures, IMN demonstrated a significant reduction in intraoperative blood loss, indicating a clear advantage in minimizing hemorrhage. Additionally, IMN showed a trend towards requiring fewer blood transfusions, although this was not statistically significant. Surgical time favored IMN with a notable reduction, and patients undergoing IMN experienced a significant decrease in both hospital stay and time to healing. However, as measured by Harris hip scores and Parker Mobility scores, functional outcomes were comparable between both techniques, suggesting similar recovery trajectories despite differences in surgical parameters. Meta-regression analysis revealed limited associations between age and sex with most outcomes, although older age correlated with longer surgical times and hospital stays. While IMN presents advantages in terms of blood loss and recovery time, the high heterogeneity across outcomes and varying quality of evidence necessitate cautious interpretation of these findings.

Our findings are consistent with previous research concerning the comparative effectiveness of IMN and DHS in managing trochanteric fractures. Specifically, our meta-analysis, along with studies by Zeelenberg et al. (2024) (89) and Zeng et al. (2012) (90), demonstrates that IMN is associated with significantly reduced intraoperative blood loss and shorter surgical durations, highlighting its efficiency as a treatment modality. Furthermore, the functional outcomes observed in our study, as measured by metrics such as Harris Hip Scores, align with findings from Huang et al. (2013) (91) and Xu et al. (2022) (92). This suggests that, despite variations in surgical parameters, patients' recovery trajectories are comparable between both techniques. The convergence of evidence underscores the potential advantages of IMN in enhancing surgical efficiency and patient safety, thereby warranting further investigation into long-term outcomes and the optimization of surgical protocols for trochanteric fractures. Notably, Yu et al. (2023) (93) reported a significant reduction in intraoperative blood loss associated with IMN, as well as its effectiveness in preventing femoral neck shortening and reducing non-union rates. These findings align with our observations of fewer blood transfusions required for IMN, although this difference did not reach statistical significance.

Despite the overall alignment with existing literature, our study reveals several noteworthy discrepancies regarding healing time and length of hospital stay. Specifically, our results indicate a significant reduction in hospital stay and healing time associated with IMN, which contrasts with the findings reported by Huang et al. (2013), where no significant differences were observed between Proximal Femoral Nail Antirotation (PFNA) and DHS. This discrepancy may be attributed to variations in patient populations, surgical techniques, or postoperative care protocols across studies. Additionally, while Zhang et al. (2023) (94) acknowledge the advantages of PFNA over DHS in various postoperative outcomes, they also highlight areas where DHS demonstrated superior performance, particularly concerning hidden blood loss. Furthermore, Yu et al. (2023) did not identify significant differences in surgical time, hospital stays, or functional scores between the two techniques. Statistical analysis comparison between our study and the previous meta-analysis is presented in Table 3.

Table 3. Statistical analysis comparison between our study and the previous meta-analysis
Study IDStudies included (N)Subgroup analysisLeave one out testcumulative analysisTSAMeta-regressionGRADE
Our studyRCTs = 31
Cohort = 29
YesYesYesYesYesYes
Zeelenberg 2024RCTs = 14
Observational = 13
NoNoNoNoNoNo
Yu 2023RCTs = 30NoYesNONoNoNo
Zhang 2023RCTs = 5
Observational = 12
NoYesNONoNoNo
Xu 2022RCTs = 12NoNoNONoNoYes
Huang 2013RCTs = 8NoYesNoNoNoNo
Zeng 2012RCTs = 13NoYesYesNoNoNo

Future research should prioritize longitudinal studies to evaluate the long-term functional recovery and complication rates associated with IMN and DHS techniques. It is essential to conduct high-quality RCTs that compare these procedures and their varied techniques to address the observed heterogeneity while controlling for variables such as fracture type and comorbidities. Cost-effectiveness analyses should also be performed to inform healthcare decision-making. Finally, exploring innovative fixation methods or modifying existing techniques may improve patient outcomes for those with trochanteric fractures.

Our study has several strengths that enhance the credibility of our findings. First, the comprehensive literature search conducted ensures a robust foundation for our analysis. Additionally, most of the included studies demonstrated high methodological quality, which further supports the reliability of our results. The large sample size significantly increases the statistical power of our findings, allowing for more generalizable conclusions. Moreover, by evaluating multiple outcomes, we provide a comprehensive overview of the effectiveness and safety of IMN compared to dynamic hip screw DHS fixation. Finally, the incorporation of Trial Sequential Analysis (TSA) adds an extra layer of rigor to our analysis, facilitating a thorough assessment of the robustness of our conclusions.

Also, we noted several points that limit the certainty of the evidence. The heterogeneity among the included studies may restrict the generalizability of our findings, as variations in study designs, patient populations, and surgical techniques could influence the outcomes. Additionally, we observed potential publication bias, especially concerning blood loss and mean surgical time. Some outcomes were constrained by insufficient sample sizes, and there was variability in follow-up durations across studies. The sensitivity analysis indicated that certain studies had a significant impact on specific outcomes, particularly regarding the open reduction of fractures and blood transfusions. Subgroup analysis Based on surgical techniques or fractures classifications was not applicable because there was not enough data.

In summary, our meta-analysis provides valuable evidence regarding the comparative effectiveness of IMN versus DHS in treating trochanteric fractures. While existing studies widely agree on the benefits of IMN in terms of reduced blood loss and improved surgical efficiency, discrepancies persist regarding healing times and length of hospital stays. Continued research is crucial to refining treatment strategies and determining the efficacy of various IMN techniques compared to different DHS approaches.